Irinotecan

ATC L01CE02 · 10 markets · 171 records

Irinotecan 10 markets · 171 records Forms

GB 53 records · 17 strengths

Other strengths: 270 mg/180 mL injection、260 mg/250 mL injection、240 mg/250 mL injection、220 mg/250 mL injection、200 mg/250 mL injection

US 27 records · 2 strengths

CN 20 records · 4 strengths

  • 100 mg/5 mLinjectionManufacturer: 上海创诺制药有限公司 ×2__mah__:仁合熙德隆药业有限公司、__mah__:四川汇宇制药股份有限公司、__mah__:江苏恒瑞医药股份有限公司、__mah__:海南锦瑞制药有限公司、__mah__:齐鲁制药(海南)有限公司 also in GB·AU
  • 40 mg/2 mLinjectionManufacturer: 上海创诺制药有限公司 ×2__mah__:仁合熙德隆药业有限公司、__mah__:哈药集团生物工程有限公司、__mah__:四川汇宇制药股份有限公司、__mah__:江苏恒瑞医药股份有限公司、__mah__:海南锦瑞制药有限公司、__mah__:齐鲁制药(海南)有限公司 also in GB
  • 100 mginjection艾力盐酸伊立替康
  • 40 mginjection艾力盐酸伊立替康

CA 12 records · 2 strengths

ES 10 records · 3 strengths

AU 7 records · 3 strengths

Records without a stated strength · 1 Meditab Irinotecan

SG 7 records · 4 strengths

MX 3 records · 1 strengths

    Records without a stated strength · 1 ANTIRIM、CETABINDO、IRIASPE

    HK 1 records · 1 strengths

      Records without a stated strength · 1 ONIVYDE PEGYLATED LIPOSOMAL CONCENTRATE FOR DISPERSION FOR INFUSION 43MG/10ML

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        Records without a stated strength · 1 ONIVYDE PEGYLATED LIPOSOMAL

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

        A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.